The ancient Egyptians, as described in the Ebers Papyrus, already knew that palpation—feeling for hardened lumps—can help diagnose breast cancer. Palpation is still an important element in early screening for breast cancer. ...
Sep 30, 2022
0
61
Medicine has advanced dramatically during the last century. But when it comes to getting biopsy results, very little has changed. Consider, for example, what happens when a patient comes in to have a skin lesion biopsied ...
Sep 27, 2022
0
73
The use of broad-spectrum antibiotics in mice with malignant melanoma, an aggressive form of skin cancer, accelerated their metastatic bone growth, likely because the drugs depleted the mice's intestinal flora and weakened ...
Sep 11, 2022
0
281
Melanopsin (OPN4) is a light-sensing protein found in skin and retina cells. A new study conducted at the University of São Paulo (USP) in Brazil suggests that OPN4 can also participate in the development and progression ...
Aug 9, 2022
0
68
An article published in Scientific Reports describes a study demonstrating the effectiveness of a peptide developed by Brazilian scientists, called Rb4, in combating cancer progression in an animal model, especially malignant ...
May 20, 2022
0
53
Immunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn't work, and new research may help explain why. When immune cells called T lymphocytes infiltrate malignant ...
May 9, 2022
0
43
Today, treatment methods are available for cancer that complement each other. Radiation therapy is frequently used, and can be combined with surgery and chemotherapy, for example. Although treatment with ionizing radiation ...
Mar 11, 2022
0
41
Many melanoma patients are treated with drugs called BRAF or MEK inhibitors that specifically target the mutant proteins created in cancerous tumors. These inhibitors can block the tumors' ability to grow and spread.
Feb 28, 2022
0
52
New findings from a landmark study indicate there may be a way to predict treatment response in breast cancer patients even before treatment begins. The study results led by Susan G. Komen Brinker Award winner Carlos Caldas, ...
Dec 8, 2021
0
63
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by ...
Nov 25, 2021
0
151
